LOOMIS SAYLES & CO L P - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 25 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,051
+5.1%
22,134
-1.2%
0.01%
-16.7%
Q4 2022$2,903
-99.9%
22,406
-9.6%
0.01%0.0%
Q3 2022$2,740,00024,7900.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 61,662,000$127,669,0004.30%
WOLVERINE ASSET MANAGEMENT LLC 94,165,000$195,054,0001.73%
SSI INVESTMENT MANAGEMENT LLC 6,418,000$13,306,0001.15%
Opti Capital Management, LP 3,625,000$7,517,0000.92%
LINDEN ADVISORS LP 32,702,000$67,675,0000.82%
Verition Fund Management LLC 14,948,000$31,032,0000.62%
ADVENT CAPITAL MANAGEMENT /DE/ 11,418,000$23,673,0000.52%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,000,000$10,382,0000.40%
AQR Arbitrage LLC 4,625,000$9,602,0000.35%
Calamos Advisors LLC 25,051,000$51,955,0000.33%
View complete list of SAREPTA THERAPEUTICS INC shareholders